Device Trial Radar · NCT05891002
Accuracy of Robotically Assisted Cranial Biopsies
Last checked: Nov 19, 2026Latest source record: Jun 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
4
Actual
Start
Nov 1, 2023
Primary completion
Jul 28, 2025
Study completion Jul 28, 2025
Sponsor
- Lead sponsor
- Brainlab AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 6, 2023
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an observational post-market study determining biopsy accuracy in a clinical environment using Cirq® Robotic Alignment Module Cranial. The goal is to determine whether the robotic procedure to be examined can achieve a clinically acceptable value of at least 90% in terms of diagnostic yield.
Conditions
- Intracranial Neoplasm
Interventions
Cirq® Robotic Alignment Module CranialDevice
Robotic navigation for cranial biopsy procedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnostic YieldTime frame: Until study termination, approx. 21 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Centre Hospitalier Universitaire (CHU) d'Angers health establishment
Angers, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.